Literature DB >> 17447419

Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus.

M Minami1, N Hamaue, M Hirafuji, H Saito, T Hiroshige, A Ogata, K Tashiro, S H Parvez.   

Abstract

A single dose of isatin (indole-2,3-dione)(i.p.), an endogenous MAO inhibitor, significantly increased norepinephrine and 5-hydroxytryptamine concentrations in the rat brain and also significantly increased acetylcholine and dopamine (DA) levels in the rat striatum. Urinary isatin concentrations in patients with Parkinson's disease tend to increase according to the severity of disease. We have developed a rat model of Parkinson's disease induced by the Japanese encephalitis virus (JEV). The distribution of the pathological lesions of JEV-rats resemble those found in Parkinson's disease. Significant behavioral improvement was observed in JEV-rats after isatin, L-DOPA and selegiline administration using a pole test. Both isatin and selegiline prevented the decrease in striatum DA levels of JEV-rats. The increased turnover of DA (DOPAC/DA) induced by JEV was significantly inhibited by isatin, but not selegiline. These findings suggest that JEV-infected rats may serve as a model of Parkinson's disease and that exogenously administered isatin and selegiline can improve JEV-induced parkinsonism by increasing DA concentrations in the striatum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17447419      PMCID: PMC7120655          DOI: 10.1007/978-3-211-33328-0_10

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  80 in total

Review 1.  Oxygen free radicals and Parkinson's disease.

Authors:  J D Adams; I N Odunze
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

2.  Monoamine oxidase, hydrogen peroxide, and Parkinson's disease.

Authors:  G Cohen
Journal:  Adv Neurol       Date:  1987

3.  Exercise increases endogenous urinary monoamine oxidase benzodiazepine receptor ligand inhibitory activity in normal children.

Authors:  I Armando; M Barontini; G Levin; R Simsolo; V Glover; M Sandler
Journal:  J Auton Nerv Syst       Date:  1984-07

4.  Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal.

Authors:  H Petursson; S K Bhattacharya; V Glover; M Sandler; M H Lader
Journal:  Br J Psychiatry       Date:  1982-01       Impact factor: 9.319

5.  Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission.

Authors:  B Scatton
Journal:  Life Sci       Date:  1982-12-20       Impact factor: 5.037

6.  New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor?

Authors:  A Clow; V Glover; I Armando; M Sandler
Journal:  Life Sci       Date:  1983-08-22       Impact factor: 5.037

7.  Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anaesthetized normotensive rats.

Authors:  M Matsumoto; H Togashi; M Yoshioka; M Hirokami; K Morii; H Saito
Journal:  J Chromatogr       Date:  1990-03-16

8.  Stress-induced synthesis of melatonin: possible involvement of the endogenous monoamine oxidase inhibitor (tribulin).

Authors:  G F Oxenkrug; I M McIntyre
Journal:  Life Sci       Date:  1985-11-04       Impact factor: 5.037

9.  Stress increases endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in rat tissues.

Authors:  I Armando; G Levin; M Barontini
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  The substantia nigra is a major target for neurovirulent influenza A virus.

Authors:  M Takahashi; T Yamada; S Nakajima; K Nakajima; T Yamamoto; H Okada
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

Review 2.  Isatin derivatives as broad-spectrum antiviral agents: the current landscape.

Authors:  Tilal Elsaman; Malik Suliman Mohamed; Eyman Mohamed Eltayib; Hatem A Abdel-Aziz; Abualgasim Elgaili Abdalla; Muhammad Usman Munir; Magdi Awadalla Mohamed
Journal:  Med Chem Res       Date:  2022-01-13       Impact factor: 2.351

3.  A Neuroprotective Dose of Isatin Causes Multilevel Changes Involving the Brain Proteome: Prospects for Further Research.

Authors:  Alexei Medvedev; Arthur Kopylov; Olga Buneeva; Leonid Kurbatov; Olga Tikhonova; Alexis Ivanov; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.